The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043739 · Cited by 1,111
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Natural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J.-M., Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 645
TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
Perner, S., Demichelis, F., Beroukhim, R., Schmidt, F. H., Mosquera, J.-M., Setlur, S., Tchinda, J., Tomlins, S. A., Hofer, M. D., Pienta, K. G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1482 · Cited by 502
TMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
Tomlins, S. A., Mehra, R., Rhodes, D. R., Smith, L. R., Roulston, D., Helgeson, B. E., Cao, X., Wei, J. T., Rubin, M. A., Shah, R. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0168 · Cited by 469
Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer
Albertsen, P. C. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530080042039 · Cited by 464
Wang, J., Cai, Y., Ren, C., & Ittmann, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1966 · Cited by 404
Prostate Cancer and the Will Rogers Phenomenon
Albertsen, P. C., Hanley, J. A., Barrows, G. H., Penson, D. F., Kowalczyk, P. D. H., Sanders, M. M., & Fine, J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji248 · Cited by 382
Interobserver reproducibility of Gleason grading of prostatic carcinoma: General pathologist
Allsbrook, W. C., Mangold, K. A., Johnson, M. H., Lane, R. B., Lane, C. G., & Epstein, J. I. (2001) · Human Pathology · doi:10.1053/hupa.2001.21135 · Cited by 380
Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists
Allsbrook, W. C., Mangold, K. A., Johnson, M. H., Lane, R. B., Lane, C. G., Amin, M. B., Bostwick, D. G., Humphrey, P. A., Jones, E. C., Reuter, V. E., et al. (2001) · Human Pathology · doi:10.1053/hupa.2001.21134 · Cited by 332
Self-citationDiversity of TMPRSS2-ERG fusion transcripts in the human prostate
Clark, J., Merson, S., Jhavar, S., Flohr, P., Edwards, S., Foster, C. S., Eeles, R., Martin, F. L., Phillips, D. H., Crundwell, M., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210070 · Cited by 271
Self-citationIljin, K., Wolf, M., Edgren, H., Gupta, S., Kilpinen, S., Skotheim, R. I., Peltola, M., Smit, F., Verhaegh, G., Schalken, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1986 · Cited by 241
Hermans, K. G., van Marion, R., van Dekken, H., Jenster, G., van Weerden, W. M., & Trapman, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1871 · Cited by 240
Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer
Soller, M. J., Isaksson, M., Elfving, P., Soller, W., Lundgren, R., & Panagopoulos, I. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20329 · Cited by 195
Yoshimoto, M., Joshua, A. M., Chilton-MacNeill, S., Bayani, J., Selvarajah, S., Evans, A. J., Zielenska, M., & Squire, J. A. (2006) · Neoplasia · doi:10.1593/neo.06283 · Cited by 185
Nam, R. K., Sugar, L., Wang, Z., Yang, W., Kitching, R., Klotz, L. H., Venkateswaran, V., Narod, S. A., & Seth, A. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.1.3489 · Cited by 164
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome
Foster, C. S., Falconer, A., Dodson, A. R., Norman, A. R., Dennis, N. M., Fletcher, A., Southgate, C., Dowe, A., Dearnaley, D. P., Jhavar, S. G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207800 · Cited by 154
Self-citationLong-term outcome among men with conservatively treated localised prostate cancer
on behalf of the Transatlantic Prostate Group, Cuzick, J. M., Fisher, G., Kattan, M. W., Berney, D. M., Oliver, R. T. D., Foster, C. S., Møller, H., Reuter, V., Fearn, P., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603411 · Cited by 134
Self-citationMelia, J., Moseley, R., Ball, R. Y., Griffiths, D. F. R., Grigor, K. M., Harnden, P., Jarmulowicz, M., McWilliam, L. J., Montironi, R., Waller, M., et al. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02393.x · Cited by 133
Bostwick, D. G., & Foster, C. S. (1999) · PubMed · Cited by 88
Self-citationLambros, M. B. K., Simpson, P. T., Jones, C., Natrajan, R., Westbury, C., Steele, D., Savage, K., Mackay, A. G., Schmitt, F. C., Ashworth, A., et al. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700390 · Cited by 87
Oyama, T., Allsbrook, W. C., Kurokawa, K., Matsuda, H., SEGAWA, A., Sano, T., Suzuki, K., & Epstein, J. I. (2005) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2005-129-1004-acoiro · Cited by 74
Cellular and Molecular Pathology of Prostate Cancer Precursors
Foster, C. S., Bostwick, D. G., Bonkhoff, H., Damber, J., van der Kwast, T., Montironi, R., & Sakr, W. A. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655900750169284 · Cited by 72
Self-citationUnderstanding and Appreciating Overdiagnosis in the PSA Era
Yao, S. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.13.958 · Cited by 65
Erratum: TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J. M., Yudi Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210630 · Cited by 21
Alpha1-adrenoceptors (?1-AR) and vascular smooth muscle cell growth
Hoffman, B. B., & Hu, Z. (2000) · The Prostate · doi:10.1002/1097-0045(2000)45:9+ · Cited by 9
Cited by
Attard, G., Reid, A. H. M., Yap, T. A., Raynaud, F., Dowsett, M., Settatree, S., Barrett, M., Parker, C., Martins, V., Folkerd, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9749 · Cited by 903
Self-citationRecurrent gene fusions in prostate cancer
Kumar-Sinha, C., Tomlins, S. A., & Chinnaiyan, A. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2402 · Cited by 664
Stott, S. L., Lee, R. J., Nagrath, S., Yu, M., Miyamoto, D. T., Ulkus, L., Inserra, E. J., Ulman, M., Springer, S., Nakamura, Z., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000403 · Cited by 539
Attard, G., Swennenhuis, J. F., Olmos, D., Reid, A. H. M., Vickers, E., A'Hern, R., Levink, R., Coumans, F., Moreira, J., Riisnaes, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3667 · Cited by 533
“For PTEN loss and ERG gene status, patients were classified into the potentially more aggressive class, i.e., homozygous versus heterozygous loss and 2+ Edel or 2+ Esplit versus Edel or Esplit.”
InfluentialSelf-citationCooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
King, J. C., Xu, J., Wongvipat, J., Hieronymus, H., Carver, B. S., Leung, D. H., Taylor, B. S., Sander, C., Cardiff, R. D., Couto, S. S., et al. (2009) · Nature Genetics · doi:10.1038/ng.371 · Cited by 477
Self-citation
Metadata
- Authors
- Attard, G., Clark, J., Ambroisine, L., Fisher, G., Kovacs, G., Flohr, P., Berney, D., Foster, C. S., Fletcher, A., Gerald, W. L., Moller, H., Reuter, V, De Bono, J. S., Scardino, P., Cuzick, J., Cooper, C. S., & on behalf of the Transatlantic Prostate Group
- Venue
- Oncogene
- Published
- 2007-07-16
- Volume
- 27
- Issue
- 3
- Pages
- 253-263
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2117936087
- Cited by
- 438
- References
- 32
- FWCI
- 32.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.